Oric Pharmaceuticals, Inc. (ORIC)
10.76
+0.01
(+0.09%)
USD |
NASDAQ |
Apr 20, 14:29
Oric Pharmaceuticals SG&A Expense (Quarterly) : 8.695M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Pfizer Inc. | 4.162B |
| Amgen, Inc. | 1.952B |
| Olema Pharmaceuticals, Inc. | 6.864M |
| Tango Therapeutics, Inc. | 9.763M |
| Tyra Biosciences, Inc. | 8.33M |